These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5693896)

  • 21. [Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hayashi N; Hibino S
    Kekkaku; 1970 Feb; 45(2):55-60. PubMed ID: 5439133
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical data on 4-4' diisoamyloxythiocarbanilide (Isoxyl).
    Hekking AM; De Voogd KK
    Antibiot Chemother; 1970; 16():128-35. PubMed ID: 4943579
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of isoniazid in one daily dose.
    Brander L; Selroos O
    Acta Tuberc Pneumol Scand; 1965; 46(3):191-6. PubMed ID: 4956375
    [No Abstract]   [Full Text] [Related]  

  • 24. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current aspects of congenital tuberculosis. Review of the literature apropos of a case beginning as otitis].
    Vaillaud JC; Sarrouy C
    Poumon Coeur; 1968; 24(2):209-27. PubMed ID: 5302244
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
    Daddi G
    Wien Med Wochenschr; 1967 Mar; 117(11):266-8. PubMed ID: 5626324
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year].
    Decroix G; Kreis B; Sors C; Birenbaum J; Le Lirzin M; Canetti G
    Rev Tuberc Pneumol (Paris); 1971; 35(1):39-54. PubMed ID: 5559724
    [No Abstract]   [Full Text] [Related]  

  • 28. Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(2):110-24. PubMed ID: 5195839
    [No Abstract]   [Full Text] [Related]  

  • 29. On the clinical effectiveness of Isoxyl.
    Tousek J
    Antibiot Chemother; 1970; 16():149-55. PubMed ID: 4943580
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biweekly treatment of pulmonary tuberculosis with isoniazid and streptomycin, with or without initial continuous phase. Results obtained in Algiers].
    Larbaoui D; Abderrahim K
    Rev Tuberc Pneumol (Paris); 1968 Jun; 32(4):572-3. PubMed ID: 5758995
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic activity and tolerance of isoxyl in pulmonary tuberculosis].
    Piazza R; Ninni A; Lorenzoni E
    Arch Tisiol Mal Appar Respir; 1966 Oct; 21(10):821-35. PubMed ID: 5300607
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rapid intravenous administration of isoniazid in treating newly detected destructive pulmonary tuberculosis].
    Shchutskaia EI; Khlebnikova LA; Derbikova TI; Ivanova GT
    Probl Tuberk; 1980 Feb; (2):41-4. PubMed ID: 7375460
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

  • 37. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 38. [Preliminary report on out-patient intermittent drug therapy in cases of active sputum-positive pulmonary tuberculosis].
    Zielniewicz B; Klimczyk M; Chodera B
    Gruzlica; 1971 Jul; 39(7):668-70. PubMed ID: 5117146
    [No Abstract]   [Full Text] [Related]  

  • 39. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb; 59(2):81-9. PubMed ID: 6379258
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical results obtained by rifomycin treatment of patients with recent tuberculosis].
    Daddi G; Lucchesi M
    Acta Tuberc Pneumol Belg; 1969; 60(3):521-6. PubMed ID: 5371677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.